Metraipolis › archive › dc_6ef08d0cb378
Public funding and private investment for R&D: a survey in China's pharmaceutical industry — Europe PMC PMID:24925505
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/24925505
- DOI
- 10.1186/1478-4505-12-27
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T00:57:57.051Z
- SHA-256 of the archived text
d1594471daffaeb24a546fe55c658f1ea1ff861085a02a80e11ef0a9cdb449c9- Stable URL of this page
https://metraipolis.com/documento/dc_6ef08d0cb378
How to cite
Public funding and private investment for R&D: a survey in China's pharmaceutical industry — Europe PMC PMID:24925505 — Europe PMC (en), https://europepmc.org/article/MED/24925505 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6ef08d0cb378 (Metraipolis archive dc_6ef08d0cb378, sha256 d1594471daffaeb24a546fe55c658f1ea1ff861085a02a80e11ef0a9cdb449c9)
BibTeX
@misc{dc6ef08d0cb378,
title = {Public funding and private investment for R&D: a survey in China's pharmaceutical industry — Europe PMC PMID:24925505},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/24925505},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6ef08d0cb378; sha256 d1594471daffaeb24a546fe55c658f1ea1ff861085a02a80e11ef0a9cdb449c9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/24925505. Agents can read the archived copy with the MCP tool read_document.